Malcolm Forbes, Mojtaba Lotfaliany, Cammie Tran, Mohammadreza Mohebbi, Robyn L Woods, John J McNeil, Michael Berk
{"title":"Testosterone Concentration and Incident Depression in Older Men: A Longitudinal Cohort Study.","authors":"Malcolm Forbes, Mojtaba Lotfaliany, Cammie Tran, Mohammadreza Mohebbi, Robyn L Woods, John J McNeil, Michael Berk","doi":"10.1093/gerona/glaf019","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Testosterone has been implicated in mood regulation, yet its role in the development and treatment of depression remains unclear. This study investigated the association between testosterone concentrations and the incidence of depression in older men.</p><p><strong>Methods: </strong>We utilized data from 4 107 men aged 70 years and older who participated in the Aspirin in Reducing Events in the Elderly (ASPREE) and ASPREE-XT studies. Serum total testosterone concentrations were measured at baseline and year 3. Depressive symptoms were assessed annually using the CES-D-10 scale, with incident depression defined as a CES-D-10 score of ≥8. Cox proportional hazards regression models were used to estimate the hazard ratios (HR) for incident depression, adjusted for potential confounders.</p><p><strong>Results: </strong>During a median follow-up of 8.4 years, 1 449 participants experienced an episode of depression. Baseline total testosterone concentrations were not significantly associated with the risk of incident depression, whether treated as continuous variables (HR 1.00, 95% CI 0.99-1.01) or when categorized into quintiles. Similarly, changes in testosterone concentrations from baseline to year 3 did not predict incident depression (aHR 1.03, 95% CI 0.99-1.08). A subgroup analysis focusing on men with biochemical evidence of hypogonadism also found no association with incident depression.</p><p><strong>Conclusions: </strong>Our findings do not support an association between testosterone concentrations and the risk of developing depression in older men. These results suggest that testosterone is not an important factor in the pathogenesis of depression in this population. There may still be individual variability in response to testosterone changes and its potential impact on mood disorders.</p>","PeriodicalId":94243,"journal":{"name":"The journals of gerontology. Series A, Biological sciences and medical sciences","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12070475/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journals of gerontology. Series A, Biological sciences and medical sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/gerona/glaf019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Testosterone has been implicated in mood regulation, yet its role in the development and treatment of depression remains unclear. This study investigated the association between testosterone concentrations and the incidence of depression in older men.
Methods: We utilized data from 4 107 men aged 70 years and older who participated in the Aspirin in Reducing Events in the Elderly (ASPREE) and ASPREE-XT studies. Serum total testosterone concentrations were measured at baseline and year 3. Depressive symptoms were assessed annually using the CES-D-10 scale, with incident depression defined as a CES-D-10 score of ≥8. Cox proportional hazards regression models were used to estimate the hazard ratios (HR) for incident depression, adjusted for potential confounders.
Results: During a median follow-up of 8.4 years, 1 449 participants experienced an episode of depression. Baseline total testosterone concentrations were not significantly associated with the risk of incident depression, whether treated as continuous variables (HR 1.00, 95% CI 0.99-1.01) or when categorized into quintiles. Similarly, changes in testosterone concentrations from baseline to year 3 did not predict incident depression (aHR 1.03, 95% CI 0.99-1.08). A subgroup analysis focusing on men with biochemical evidence of hypogonadism also found no association with incident depression.
Conclusions: Our findings do not support an association between testosterone concentrations and the risk of developing depression in older men. These results suggest that testosterone is not an important factor in the pathogenesis of depression in this population. There may still be individual variability in response to testosterone changes and its potential impact on mood disorders.
背景:睾酮与情绪调节有关,但其在抑郁症的发展和治疗中的作用尚不清楚。这项研究调查了睾酮浓度与老年男性抑郁症发病率之间的关系。方法:我们使用了4107名70岁及以上的男性的数据,他们参加了阿司匹林在减少老年人事件(ASPREE)和ASPREE- xt研究。在基线和第3年测定血清总睾酮浓度。每年使用CES-D-10量表评估抑郁症状,发生率抑郁定义为CES-D-10评分≥8。Cox比例风险回归模型用于估计事件抑郁症的风险比(HR),并对潜在混杂因素进行调整。结果:在中位随访8.4年期间,1449名参与者经历了抑郁症发作。无论作为连续变量(HR 1.00, 95% CI 0.99-1.01)还是按五分位数分类,基线总睾酮浓度与抑郁症发生风险均无显著相关性。同样,睾酮浓度从基线到第3年的变化并不能预测抑郁症的发生(aHR 1.03, 95% CI 0.99-1.08)。一项针对有性腺功能减退生化证据的男性的亚组分析也发现与偶发性抑郁症没有关联。结论:我们的研究结果不支持睾酮浓度与老年男性患抑郁症风险之间的联系。这些结果表明睾酮在这一人群中并不是抑郁症发病的重要因素。对睾酮变化的反应及其对情绪障碍的潜在影响可能仍存在个体差异。